Sequential therapy or standard triple therapy for helicobacter pylori infection: An updated systematic review

American Journal of Therapeutics

Volumn 23, Issue 3, 2016, Pages e880-e893

  Feng, Li ^a   Wen, Mao Yao ^a   Zhu, Yong Jun ^b   Men, Ruo Ting ^a   Yang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b Second People's Hospital of Chengdu   (China)

Author keywords

eradication; Helicobacter pylori; meta analysis; sequential therapy; standard triple therapy

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; TINIDAZOLE; AMOXICILLIN; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DRUG EFFICACY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICATION COMPLIANCE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SYSTEMATIC REVIEW; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; DRUG EFFECTS; HELICOBACTER INFECTIONS;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMP INHIBITORS;

EID: 84920613998     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000191     Document Type: Article

References (53)

1. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009; 24: 1587-1600
2. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102: 1808-1825
3. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56: 772-781
4. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010; 59: 1143-1153
5. Gisbert JP, Pajares R, Pajares JM. Evolution of Helicobacter pylori therapy from a meta-analytical perspective. Helicobacter. 2007; 12(Suppl 2): 50-58
6. Gerrits MM, van Vliet AH, Kuipers EJ, et al. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. 2006; 6: 699-709
7. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology. 2007; 133: 985-1001
8. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000; 14: 715-718
9. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62: e1-34
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62: 1006-1012
11. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17: 1-12
12. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560
13. Focareta R, Forte G, Ciarlegio A, et al. Helicobacter pylori eradication: one week triple therapy vs. 10-day sequential regimen introduction. Dig Liver Dis. 2002; 34: A17
14. Focareta R, Forte G, Forte F, et al. Could the 10-days sequential therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection. Dig Liver Dis. 2003; 35(Suppl 4): S33
15. Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther. 2003; 17: 719-726
16. De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther. 2004; 19: 407-414
17. De Francesco V, Zullo A, Hassan C, et al. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Dig Liver Dis. 2004; 36: 322-326
18. Zullo A, Gatta L, De Francesco V, et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther. 2005; 21: 1419-1424
19. Scaccianoce G, Hassan C, Panarese A, et al. Helicobacter pylori eradication with either seven-day or 10-day triple therapies, and with a 10-day sequential regimen. Can J Gastroenterol. 2006; 20: 113-117
20. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication- A randomized trial. Ann Intern Med. 2007; 146: 556-563
21. Choi WH, Park DI, Oh SJ, et al. Effectiveness of 10 daysequential therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol. 2008; 51: 280-284
22. Ma CX, Peng GL, Zhao YK, et al. Treatment outcomes of functional dyspepsia patients with Helicobacter pylori infection: a comparison between sequential treatment regimen and conventional triple therapy. Acad J Second Mil Med Univ. 2008; 29: 908-911
23. Zhao QX, Huang DY. Efficacy of tinidazole-containing sequential therapy in the eradication of Helicobacter pylori infection. World Chinese J Digestology. 2009; 17: 3666-3669
24. Aminian K, Farsad F, Ghanbari A, et al. A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. Trop Gastroenterol. 2010; 31: 303-307
25. Gao XZ, Qiao XL, Song WC, et al. Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. World J Gastroenterol. 2010; 16: 4357-4362
26. Paoluzi OA, Visconti E, Andrei F, et al. Ten and eightday sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. J Clin Gastroenterol. 2010; 44: 261-266
27. Molina-Infante J, Perez-Gallardo B, Fernandez-Bermejo M, et al. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2010; 31: 1077-1084
28. Greenberg ER, Anderson GL, Morgan DR, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011; 378: 507-514
29. Kim YS, Kim SJ, Yoon JH, et al. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther. 2011; 34: 1098-1105
30. Gatta L, Vaira D, Vakil NB, et al. Sequential therapy vs. standard triple therapy lasting 7 days: results of a prospective study. Gastroenterology. 2011; 140: S-148
31. Wu GL, Lan Y, Zhang XJ. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication. World Chinese J Digestology. 2011; 19: 3100-3103
32. Yan X, Zhou L, Song Z, et al. Sequential therapy for Helicobacter pylori eradication in adults compared with triple therapy in China: a multiple center, prospective, randomized, controlled trial. Helicobacter. 2011; 16: 87
33. Chung J, Jung YK, Kim YJ, et al. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. J Gastroenterol Hepatol. 2012; 27: 1675-1680
34. Choi HS, Chun HJ, Park SH, et al. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. World J Gastroenterol. 2012; 18: 2377-2382
35. Oh HS, Lee DH, Seo JY, et al. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. J Gastroenterol Hepatol. 2012; 27: 504-509
36. Park HG, Jung MK, Jung JT, et al. Randomised clinical trial: Comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients. Aliment Pharmacol Ther. 2012; 35: 56-65
37. Hsu PI, Wu DC, Chen WC, et al. Comparison of 7-day triple, 10-day sequential and 7-day concomitant therapies for Helicobacter pylori infection in Taiwan. J Gastroenterol Hepatol. 2012; 27: 421
38. Javid G, Zargar SA, Bhat K, et al. Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial. Indian J Gastroenterol. 2013; 32: 190-194
39. Jeon WK, Park DI, Sohn CI. Effectiveness of 10 daysequential treatment for Helicobacter pylori eradication in Korea. Gastroenterology. 2013; 144(Suppl 5): S567-S568
40. Lahbabi M, Alaoui S, El Rhazi K, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: result of the HPFEZ randomised study. Clin Res Hepatol Gastroenterol. 2013; 37: 416-421
41. Liou JM, Chen CC, Chen MJ, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2013; 381: 205-213
42. Morse AL, Goodman KJ, Munday R, et al. A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North. Can J Gastroenterol. 2013; 27: 701-706
43. Nasa M, Choksey A, Phadke A, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study. Indian J Gastroenterol. 2013; 32: 392-396
44. Seddik H, Ahid S, El Adioui T, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study. Eur J Clin Pharmacol. 2013; 69: 1709-1715
45. Yep-Gamarra V, Rodriguez-Ulloa C, Diaz-Velez C, et al. Sequential versus triple standard therapy for Helicobacter pylori eradication. Gastroenterology. 2013; 144 (Suppl 5): S333
46. Song M, Ang TL, Fock KM. An update: a randomized controlled trial of triple therapy versus sequential therapy versus concomitant therapy as first line treatment for H. Pylori infection in Singapore. Gastroenterology. 2014; 146(Suppl 5): S104-S105
47. Eisig JN, Navarro-Rodriguez T, Teixeira AC, et al. Standard triple therapy for Helicobacter pylori is still the best first line treatment in Brazil, compared with sequential therapy: a randomized, prospective, double-blind, placebo-controlled study. Gastroenterology. 2014; 146(Suppl 5): S390
48. Zhou L, Zhang J, Chen M, et al. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. Am J Gastroenterol. 2014; 109: 535-541
49. Janssen MJ, Van Oijen AH, Verbeek AL, et al. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. Aliment Pharmacol Ther. 2001; 15: 613-624
50. Laheij RJF, Van Rossum LGM, Jansen JBMJ, et al. Evaluation of treatment regimens to cure Helicobacter pylori infection- A meta-analysis. Aliment Pharmacol Ther. 1999; 13: 857-864
51. Glupczynski Y, Megraud F, Lopez-Brea M, et al. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 2001; 20: 820-823
52. Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013; 62: 34-42
53. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection- The maastricht IV/Florence consensus report. Gut. 2012; 61: 646-664